Investigation path
FIND
AstraZeneca PLC
AZN
RESOLVE
Backed Assets
1 issuer
TRACE
2 tokenized representations
AZNX · WAZNX
UnderScope Lens
Representation check
A compact comparison of AstraZeneca PLC across the reported market reference, tokenized aggregate, and issuer wrappers.
Market reference
—
No priced CMC venue reference
Tokenized aggregate
$133.19
Aggregate wrapper price
Wrapper dispersion
—
1 priced wrapper · single wrapper
The Lens needs both a priced tokenized representation and a priced CMC market reference to compare parity.
Underlier
AstraZeneca PLC[AZN]
Stock · Nasdaq
Tokenized price
$133.19
Rank #60
- Primary exchange
- Nasdaq
- Founded
- 1999-04-06
- Employees
- 94,300
- CIK
- 0000901832
Tokenized market cap
$163.45K
24h tokenized volume
$218.96K
Tokenized exposure
2wrappers
Source
Average across issuer wrappers, not a cash last
Real-world asset
About the underlier
The instrument being tokenized — not the on-chain wrapper.
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing…
- Rank
- 60
- Asset type
- Stock
- Primary exchange
- Nasdaq
- Founded
- 1999-04-06
- Employees
- 94,300
- SEC CIK
- 0000901832